This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Top Stock Reports for Apple, JPMorgan Chase & Visa
by Mark Vickery
AAPL, JPM, and V lead Zacks' top picks as Services growth, strong NII, and digital payments momentum drive investor interest.
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
by Zacks Equity Research
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HealthEquity (HQY) Upgraded to Buy: Here's Why
by Zacks Equity Research
HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GDRX vs. HQY: Which Stock Is the Better Value Option?
by Zacks Equity Research
GDRX vs. HQY: Which Stock Is the Better Value Option?
Why Is HealthEquity (HQY) Down 10.4% Since Last Earnings Report?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now
by Zacks Equity Research
HQY's sustained strength in HSAs raises optimism about the stock.
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EGO or AEM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EGO vs. AEM: Which Stock Is the Better Value Option?
FLR vs. PWR: Which Stock Is the Better Value Option?
by Zacks Equity Research
FLR vs. PWR: Which Stock Is the Better Value Option?
KRYAY or MDLZ: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
KRYAY vs. MDLZ: Which Stock Is the Better Value Option?
CPRX vs. NBIX: Which Stock Is the Better Value Option?
by Zacks Equity Research
CPRX vs. NBIX: Which Stock Is the Better Value Option?
MD or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MD vs. HQY: Which Stock Is the Better Value Option?
BSAC or NU: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BSAC vs. NU: Which Stock Is the Better Value Option?
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HealthEquity (HQY) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
MD or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MD vs. HQY: Which Stock Is the Better Value Option?
ECL Stock Gains Following Latest Launch to Boost Data Center Cooling
by Zacks Equity Research
Ecolab's 3D TRASAR technology expands its cooling solutions, aiming to optimize data centers and cut resource demand.
Company News for Jun 5, 2025
by Zacks Equity Research
Companies in The News Are: HPE,CRWD,GWRE,HQY
Zacks Investment Ideas feature highlights: Ollie's Bargain Outlet and HealthEquity
by Zacks Equity Research
OLLI and HQY beat Q1 estimates as expansion and health savings strategies drive growth in uncertain times.
2 Buy-Rated Stocks to Watch After Strong Q1 Results: OLLI, HQY
by Shaun Pruitt
Ollie's Bargain Outlet (OLLI) and HealthEquity (HQY) have implemented successful growth strategies that investors are surely looking for.